$ News

Adaptimmune Announces Changes to Board and Executive Leadership Team

European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading

European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading; End Week 2.3% Higher

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

European Equities Traded in the US as American Depositary Receipts Start Week Slightly Lower in Monday Trading

Adaptimmune Reports Q2 Financial Results and Provides Business Update

US WorldMeds Completes Acquisition of Adaptimmune's Cell-Therapy Portfolio; Ensures Continued Patient Access to Tecelra and Advances Development of lete-cel

European Equities Fall in Monday Trading; EU Strikes Trade Deal With US

European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading

European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

Adaptimmune Therapeutics PLC (ADAP) Q1 2025 Earnings Call Highlights: Strong Tecelra Launch ...

Adaptimmune Therapeutics plc (ADAP) Q1 2025 Earnings Call Transcript

Adaptimmune Reports Q1 Financial Results and Provides Business Update

Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025

ADAP 4Q24 Earnings Review: EPS Miss on 1x Restructuring/Impairment Costs; Potential Capital Raise Adds Risk to the Story